1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neuromodulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neuromodulation Devices Market, North America
3.1 Neuromodulation Devices Market, North America, Revenue ($m), 2018-2033
3.2 Neuromodulation Devices Market, North America, Revenue ($m), 2018-2033
3.3 Neuromodulation Devices Market, North America, Volume (Units), 2018-2033
3.4 Neuromodulation Devices Market, North America, Volume (Units), 2018-2033
3.5 Neuromodulation Devices Market, North America, Company Share by Revenue ($m), 2025
4 Neuromodulation Devices Market, Canada
4.1 Neuromodulation Devices Market, Canada, Revenue ($m), 2018-2033
4.1.1 Implantable Neuromodulation Devices Market, Canada, Revenue ($m), by Segment, 2018-2033
4.2 Neuromodulation Devices Market, Canada, Volume (Units), 2018-2033
4.2.1 Implantable Neuromodulation Devices Market, Canada, Volume (Units), by Segment, 2018-2033
4.3 Neuromodulation Devices Market, Canada, Average Price ($), 2018-2033
4.4 Neuromodulation Devices Market, Canada, Company Share by Revenue ($m), 2025
5 Neuromodulation Devices Market, Mexico
5.1 Neuromodulation Devices Market, Mexico, Revenue ($m), 2018-2033
5.1.1 Implantable Neuromodulation Devices Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.2 Neuromodulation Devices Market, Mexico, Volume (Units), 2018-2033
5.2.1 Implantable Neuromodulation Devices Market, Mexico, Volume (Units), by Segment, 2018-2033
5.3 Neuromodulation Devices Market, Mexico, Average Price ($), 2018-2033
5.4 Neuromodulation Devices Market, Mexico, Company Share by Revenue ($m), 2025
6 Neuromodulation Devices Market, United States
6.1 Neuromodulation Devices Market, United States, Revenue ($m), 2018-2033
6.1.1 Implantable Neuromodulation Devices Market, United States, Revenue ($m), by Segment, 2018-2033
6.2 Neuromodulation Devices Market, United States, Volume (Units), 2018-2033
6.2.1 Implantable Neuromodulation Devices Market, United States, Volume (Units), by Segment, 2018-2033
6.3 Neuromodulation Devices Market, United States, Average Price ($), 2018-2033
6.4 Neuromodulation Devices Market, United States, Company Share by Revenue ($m), 2025
7 Overview of Key Companies in North America Neuromodulation Devices Market
7.1 Medtronic Plc
7.1.1 Company Overview
7.2 Boston Scientific Corp
7.2.1 Company Overview
7.3 Abbott Laboratories
7.3.1 Company Overview
7.4 LivaNova Plc
7.4.1 Company Overview
7.5 Nevro Corp
7.5.1 Company Overview
7.6 Axonics Inc
7.6.1 Company Overview
7.7 NeuroPace Inc
7.7.1 Company Overview
8 Neuromodulation Devices Market Pipeline Products
9 Recent Developments
9.1 Corporate Communications
9.1.1 Nov 25, 2025: SetPoint Medical to Present at Piper Sandler 37th Annual Healthcare Conference
9.1.2 Nov 20, 2025: PhotoPharmics Exceeds Enrollment Goal with 350 Participants in Remote Phase 3 Clinical Trial for Parkinson’s Disease
9.1.3 Nov 18, 2025: NeuroSigma Launches Next-Generation Monarch Device for Pediatric ADHD
9.1.4 Nov 17, 2025: Autonomix Medical, Inc. Reports Positive Subgroup Results Demonstrating Sustained Improvements in Quality of Life from Post Hoc Analysis of Pancreatic Cancer PoC Study
9.1.5 Nov 17, 2025: MicroTransponder Appoints Dana G. Mead, Jr. as Chair and Cynthia Lucchese as Independent Director
9.1.6 Nov 10, 2025: TEDCO Announces Recent Company Formation and Technology Assessment Awardees
9.1.7 Nov 06, 2025: Synchron Secures $200 Million Series D Funding for Brain-Computer Interface Development
9.1.8 Nov 06, 2025: PhotoPharmics Exceeds Enrollment Target with 350 Participants in Remote Clinical Trial
9.1.9 Nov 05, 2025: Curonix Appoints Russell Fleeger as Chief Financial Officer
9.1.10 Nov 04, 2025: BrainsWay Announces NIH Grant for Research on Accelerated Deep TMS for Alcohol Use Disorder
9.1.11 Nov 03, 2025: Katrina Rouan Appointed Director of the Walter P. Reuther Library Archives of Labor and Urban Affairs
9.1.12 Oct 30, 2025: End Brain Cancer Initiative Partners with Exvade Bioscience to Raise Awareness of Brain Cancer Study
9.1.13 Oct 30, 2025: Siddiqui Performs World’s First Robotic Microsurgical Intracranial Brain Surgery
9.1.14 Oct 24, 2025: Payman Khales Becomes Integer President and CEO
9.1.15 Oct 23, 2025: Miramont Wellness Centers Introduces New Device and Program for Treating Depression
9.1.16 Oct 21, 2025: DCMH Welcomes Dr. Bryan Schatmeyer, Spine Surgeon
9.1.17 Oct 21, 2025: Wayne State University Appoints New Director of the Institute of Gerontology
9.1.18 Oct 20, 2025: Spark Biomedical Receives NIH Grant to Investigate tAN Technology for Alcohol Withdrawal Symptoms
9.1.19 Oct 16, 2025: Wayne State Delegation Shares Expertise at National Science Foundation Workshop
9.1.20 Oct 14, 2025: Zynex Appoints Bret Wise as Audit Committee Chair
9.1.21 Oct 14, 2025: Jessica Rajko Appointed Acting Associate Dean of Academic and Faculty Affairs
9.1.22 Oct 10, 2025: Nexalin Technology Attends the 2025 Maxim Growth Summit
9.1.23 Oct 07, 2025: New Leadership Appointments Announced by Wayne State University's Vice President for Research & Innovation
9.1.24 Oct 02, 2025: Wayne State University Collaboration With Applied Materials Supports Faculty Research And Career Pathways
9.1.25 Oct 01, 2025: Cirtec Medical Appoints Steven Chevillotte To Board Of Directors
9.1.26 Sep 25, 2025: Joe Hedges Appointed New Associate Director of David G. Pollart Center for Arts and Humanities
9.1.27 Sep 24, 2025: Phase 3 Compass Pws Trial Of Intranasal Carbetocin Fails To Meet Primary Endpoint
9.1.28 Sep 24, 2025: CWSL Alumna Sherry S. Bahrambeygui Elected to UC San Diego Foundation Board
9.1.29 Sep 16, 2025: Investment in Neurotechnology Innovation
9.1.30 Sep 16, 2025: Cirtec Medical Welcomes Chris Cleary to its Board of Directors
9.1.31 Sep 15, 2025: Inbrain Neuroelectronics Collaborates to Enhance Graphene-Based Brain-Computer Interfaces
9.1.32 Sep 15, 2025: Kelly Young Appointed Interim Dean for College of Fine, Performing and Communication Arts
9.1.33 Sep 08, 2025: UC San Diego Foundation Announces New Trustees
9.1.34 Sep 05, 2025: Wayne State Anthropology Museum Receives $1.3 Million Bequest
9.1.35 Aug 05, 2025: Avanos Medical Appoints Scott Galovan as CFO and David Pacitti to Board of Directors
9.1.36 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
9.1.37 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
9.1.38 Feb 13, 2025: Tim Ryan Elected to Battelle Board of Directors
9.2 Financial Announcements
9.2.1 Jan 09, 2026: Sanuwave Health Reports Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-Over-Year
9.2.2 Nov 12, 2025: Solana Company to Release Third Quarter Operating Results
9.2.3 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results
9.2.4 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
9.2.5 Jul 29, 2025: NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025
9.2.6 Jul 24, 2025: Avanos Medical to Webcast Conference Call Discussing Second Quarter 2025 Financial Results
9.3 Government and Public Interest
9.3.1 Nov 25, 2025: SetPoint Medical to Present at Piper Sandler 37th Annual Healthcare Conference
9.3.2 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
9.3.3 Oct 30, 2025: The Enrollment for Phase III Trial of the Company’s Nivolumab Injection Has Been Completed in China
9.3.4 Oct 27, 2025: Inspire Medical Systems, Inc. To Present At The 2025 UBS Global Healthcare Conference
9.3.5 Oct 22, 2025: Vivani Medical to Present at ThinkEquity Conference
9.3.6 Oct 10, 2025: Nexalin Technology Attends the 2025 Maxim Growth Summit
9.3.7 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium
9.3.8 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results
9.3.9 Sep 24, 2025: Vivani Medical To Present At The Emerging Growth Conference
9.3.10 Sep 24, 2025: Eysz Announces Positive Results of NIH-Funded Study on Novel Absence Seizure Screening Tool
9.3.11 Sep 02, 2025: Compelling Data at ESC Congress 2025 Reinforce Safety and Performance of the Medtronic Omniasecure Defibrillation Lead, Including in the Left Bundle Branch Area
9.3.12 Aug 12, 2025: Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4
9.3.13 Aug 04, 2025: Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference
9.3.14 Jul 22, 2025: electroCore to Participate in Upcoming Investor Conferences
9.3.15 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
9.3.16 Mar 26, 2025: NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference
9.3.17 Mar 03, 2025: NeuroPace to Present at the Leerink Partners Global Healthcare Conference
9.3.18 Feb 28, 2025: SK Bioscience Wins Additional Varicella Vaccine Orders in Latin America
9.4 Legal And Regulatory
9.4.1 Jan 15, 2026: Zynex : Update
9.4.2 May 23, 2025: All Samples Analyzed From the 30 MG Dose Group in the Nex-22 Phase I Study
9.4.3 Apr 10, 2025: Genflow Biosciences Launches New Ophthalmology Development Program Signs MTA with Leading Ophthalmology Company
9.5 Other Significant Developments
9.5.1 Jan 30, 2026: Astellas Submits Supplemental NDA in Japan for PADCEV with Keytruda (pembrolizumab) for Certain Patients with Muscle-Invasive Bladder Cancer
9.5.2 Nov 24, 2025: NeuroPace Announces Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services
9.5.3 Nov 24, 2025: SetPoint Medical Receives CMS Transitional Pass-Through Payment Approval for SetPoint System
9.5.4 Nov 20, 2025: Nexstim Receives NBS 6 System Order From New Research Customer
9.5.5 Nov 17, 2025: Autonomix Medical, Inc. Reports Positive Subgroup Results Demonstrating Sustained Improvements in Quality of Life from Post Hoc Analysis of Pancreatic Cancer PoC Study
9.5.6 Nov 12, 2025: NeurAxis Announces Medical Policy Coverage Expansion in Michigan
9.5.7 Nov 10, 2025: Hope Therapeutics, Inc. Announces First-in-Florida Initiation of One Day Depression Treatment
9.5.8 Nov 04, 2025: BrainsWay Announces NIH Grant for Research on Accelerated Deep TMS for Alcohol Use Disorder
9.5.9 Nov 04, 2025: Free Early Detection Alzheimer’s Tests in Dearborn, MI
9.5.10 Nov 03, 2025: Cefaly Achieves Milestone as Most Prescribed Neuromodulation Device by Veterans Health Administration
9.5.11 Oct 24, 2025: Laser Procedure Offers Solutions For Epilepsy And Brain Tumors
9.5.12 Oct 20, 2025: Spark Biomedical Receives NIH Grant to Investigate tAN Technology for Alcohol Withdrawal Symptoms
9.5.13 Oct 13, 2025: Onward Medical Provides Q3 2025 Update on ARC-EX Adoption
9.5.14 Oct 07, 2025: Nexstim Receives System Order From US Clinic
9.5.15 Oct 06, 2025: Study Shows Cala TAPS Therapy Reduces Hand Tremor in Essential Tremor Patients by Modulating Brain Activity
9.5.16 Oct 06, 2025: NeuroOne Reports 163% Growth in Preliminary Unaudited Product Revenue to $9.1 Million
9.5.17 Oct 02, 2025: CLDN18.2 CaAR-T Cells Eliminate Pancreatic Cancer Cells
9.5.18 Sep 18, 2025: Panaxium Research Signs Exclusive IP Agreement With University of Washington
9.5.19 Sep 17, 2025: Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders
9.5.20 May 25, 2025: Biocon Biologics Receives MHRA, UK Approval for YESINTEK, Biosimilar Ustekinumab
9.5.21 Apr 02, 2025: NeuroPace Announces Refocusing of Product Portfolio
9.6 Product News
9.6.1 Jan 28, 2026: Integer to Highlight Integrated R&D Solutions and Expanded Coating Capabilities at MD&M West 2026
9.6.2 Jan 28, 2026: Advancing Brain-Based Therapeutics to the Forefront of Addiction Care
9.6.3 Jan 14, 2026: Integer to Showcase Innovations in Neuromodulation, Miniaturized Active Implantable Device Technology During NANS 2026 Annual Meeting
9.6.4 Jan 08, 2026: Surf Therapeutics Announces Early Feasibility Study (EFS) To Advance Non-Invasive Approach to Neuromodulation for Rheumatoid Arthritis
9.6.5 Nov 28, 2025: Yale-Trained Neuroscientist Introduces Panbrain Lume "Digital Sunshine" Device to Improve Sleep
9.6.6 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
9.6.7 Nov 24, 2025: SetPoint Medical Receives CMS Transitional Pass-Through Payment Approval for SetPoint System
9.6.8 Nov 20, 2025: Paradromics Receives FDA Approval for Connect-One Clinical Study with Connexus Brain-Computer Interface
9.6.9 Nov 20, 2025: PhotoPharmics Exceeds Enrollment Goal with 350 Participants in Remote Phase 3 Clinical Trial for Parkinson’s Disease
9.6.10 Nov 20, 2025: Neuralink Rival Paradromics Cleared to Begin Brain-Implant Trial
9.6.11 Nov 18, 2025: QuantalX Receives FDA De Novo Clearance for Delphi-MD
9.6.12 Nov 17, 2025: BrainsWay Launches Clinical Trial of Deep TMS 360 System for Alcohol Use Disorder
9.6.13 Nov 15, 2025: Evidence Builds for Disrupted Mitochondria as Cause of Parkinson’s
9.6.14 Nov 13, 2025: BrainsWay Receives FDA Clearance for Deep TMS as Adjunct Therapy for Major Depressive Disorder in Adolescents
9.6.15 Nov 12, 2025: NeurAxis Announces Medical Policy Coverage Expansion in Michigan
9.6.16 Nov 12, 2025: Theranica's Nerivio REN Wearable Demonstrates Long-Term Efficacy in Migraine Treatment
9.6.17 Nov 10, 2025: URI Team Develops Tabletop Device to Study Long-Term Effects of Traumatic Brain Injury
9.6.18 Nov 06, 2025: Synchron Secures $200 Million Series D Funding for Brain-Computer Interface Development
9.6.19 Nov 06, 2025: PhotoPharmics Exceeds Enrollment Target with 350 Participants in Remote Clinical Trial
9.6.20 Nov 06, 2025: NeuroCytonix Receives COFEPRIS Authorization for Neuro-Restorative Treatment in Mexico
9.6.21 Nov 05, 2025: Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for Alzheimer’s Treatment
9.6.22 Nov 05, 2025: MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
9.6.23 Nov 03, 2025: Cefaly Achieves Milestone as Most Prescribed Neuromodulation Device by Veterans Health Administration
9.6.24 Nov 03, 2025: NeuroSigma Publishes Study on Real-Time Effects of External Trigeminal Nerve Stimulation on Brain Activity
9.6.25 Oct 31, 2025: European Investment Bank Supports German MedTech with €20 Million for PRECISIS
9.6.26 Oct 30, 2025: Nexalin Technology Receives Regulatory Approval for Gen 2 SYNC Neurostimulation Device in Israel
9.6.27 Oct 30, 2025: Siddiqui Performs World’s First Robotic Microsurgical Intracranial Brain Surgery
9.6.28 Oct 29, 2025: Incision-Free Brain Surgery Restores Smile for Parkinson's Patient
9.6.29 Oct 29, 2025: FDA-Approved Focused Ultrasound Treatment for Essential Tremor Now Used for Parkinson's
9.6.30 Oct 28, 2025: OHSU First In Nation To Use New Incisionless Surgery For Parkinson’s Treatment
9.6.31 Oct 24, 2025: NeurAxis Receives FDA Clearance for Pain Treatment in Functional Dyspepsia
9.6.32 Oct 23, 2025: Miramont Wellness Centers Introduces New Device and Program for Treating Depression
9.6.33 Oct 21, 2025: Nexalin’s DIFS Neurostimulation Demonstrates Cognitive Improvements in Alzheimer’s and Dementia
9.6.34 Oct 20, 2025: Neupulse Partnership Introduces Innovative Wearable for Tourette Syndrome
9.6.35 Oct 14, 2025: NeuroOne Expands Patent Portfolio With Recent USPTO and EPO Decisions
9.6.36 Oct 13, 2025: Onward Medical Provides Q3 2025 Update on ARC-EX Adoption
9.6.37 Oct 13, 2025: Zeta Surgical TMS Navigation System Receives FDA Clearance
9.6.38 Oct 08, 2025: Nexalin Technology Reports Positive Clinical Results for Alzheimer’s with Gen-2 SYNC Device
9.6.39 Oct 07, 2025: Oxeia Biopharmaceuticals Recognized As Most Innovative Mild Traumatic Brain Injury Company for 2025
9.6.40 Oct 06, 2025: Study Shows Cala TAPS Therapy Reduces Hand Tremor in Essential Tremor Patients by Modulating Brain Activity
9.6.41 Oct 01, 2025: BalanceWear® for Multiple Sclerosis: Enhance Stability and Mobility
9.6.42 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium
9.6.43 Sep 25, 2025: Nexalin Technology Issues U.S. Patent for HALO Clarity Device with DIFS Technology
9.6.44 Sep 24, 2025: Eysz Announces Positive Results of NIH-Funded Study on Novel Absence Seizure Screening Tool
9.6.45 Sep 23, 2025: FDA Clears Cionic Neural Sleeve 2 For Enhanced Mobility Care
9.6.46 Sep 19, 2025: Medtronic Receives FDA Approval for Altaviva Device to Treat Urge Urinary Incontinence
9.6.47 Sep 18, 2025: Panaxium Research Signs Exclusive IP Agreement With University of Washington
9.6.48 Sep 17, 2025: Soft Bioelectronic Fiber Tracks Hundreds of Biological Events Simultaneously
9.6.49 Sep 16, 2025: Non-Invasive Neuromodulation Boosts Physical Therapy
9.6.50 Sep 15, 2025: Inbrain Neuroelectronics Collaborates to Enhance Graphene-Based Brain-Computer Interfaces
9.6.51 Sep 10, 2025: Neurocare Group's Apollo TMS Therapy Devices Granted FDA Clearance for Treating Adolescent Depression
9.6.52 Sep 08, 2025: Onward Medical Receives CE Mark for Arc-Ex, Enabling Commercial Launch in Europe
9.6.53 Aug 20, 2025: Vivani Medical CEO Adam Mendelsohn To Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025
9.6.54 Jul 30, 2025: Neurotek Announces Debut of MOXO360
9.6.55 May 28, 2025: Nyxoah to Present at the Jefferies Global Healthcare Conference
9.6.56 Mar 03, 2025: KYOCERA to Showcase Ceramic Lab Analytic Technologies for Multilayer Direct Bonding, Ceramic Additive Manufacturing, and Sapphire Apertures at Pittcon 2025
9.7 Strategy And Business Planning
9.7.1 Nov 13, 2025: Nexalin Technology Appoints Carmi Masha Technologies Ltd. As Exclusive Distributor In Israel
9.7.2 Nov 12, 2025: NeurAxis Announces Medical Policy Coverage Expansion in Michigan
9.7.3 Nov 06, 2025: Synchron Secures $200 Million Series D Funding for Brain-Computer Interface Development
9.7.4 Oct 31, 2025: European Investment Bank Supports German MedTech with €20 Million for PRECISIS
9.7.5 Oct 30, 2025: Nexalin Technology Receives Regulatory Approval for Gen 2 SYNC Neurostimulation Device in Israel
9.7.6 Sep 18, 2025: Panaxium Research Signs Exclusive IP Agreement With University of Washington
9.7.7 Sep 17, 2025: Vivani Medical Sets Record Date for Cortigent Spin-off
9.7.8 Sep 15, 2025: Inbrain Neuroelectronics Collaborates to Enhance Graphene-Based Brain-Computer Interfaces
9.7.9 Apr 24, 2025: Cirtec Medical Expands Costa Rica Operations to Support Increased Industry Demand
9.7.10 Mar 13, 2025: Helius Medical Technologies Announces the Establishment of a Wholly Owned Brain Computer Interface (“Bci”) Technology Private Subsidiary
10 Appendix
10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Benchmarking
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer
